[ Price : $8.95]
The Kaiser Permanente healthcare system calls for FDA and congressional changes to improve the utility of the drug accelerated app...[ Price : $8.95]
FDA approves an Astellas Pharma supplemental NDA for Izervay (avacincaptad pegol intravitreal solution) that revises the labeling ...[ Price : $8.95]
A Buchannan Ingersoll petition asks FDA to impose conditions on ANDAs for generic forms of the cancer drug Leukeran.[ Price : $8.95]
Endo asks FDA not to receive or approve any applications for a generic form of Endos epinephrine products that do not refer to the...[ Price : $8.95]
The U.S. Senate votes 52-48 to confirm vaccine skeptic Robert F. Kennedy Jr. to serve as the next HHS secretary.[ Price : $8.95]
Researchers in China say they found several new adverse event signals in their review of 20 years of FDA adverse event reports on ...[ Price : $8.95]
Travere Therapeutics says it will submit an sNDA to FDA for a new indication for its Filspari to treat focal segmental glomerulosc...[ Price : $8.95]
FDA approves a Pfizer supplemental BLA for Adcetris (brentuximab vedotin) in combination with lenalidomide and rituximab for treat...